XML 63 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Series A Redeemable Convertible Preferred Stock
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Comprehensive Income / Loss
Accumulated Deficit
Noncontrolling Interest
Total
Beginning balance, shares at Dec. 31, 2017 0 50,639,926            
Beginning balance, value at Dec. 31, 2017 $ 0 $ 51 $ (34,640) $ 648,996 $ (88) $ (320,018) $ 1,358 $ 295,659
Net loss attributable to Acacia Research Corporation           (105,029)   (105,029)
Cumulative effect of new accounting principle           2,506 308 2,814
Stock options exercised, shares   82,615            
Stock options exercised, value       257       257
Compensation expense for share-based awards, net of forfeitures, shares   166,998            
Compensation expense for share-based awards, net of forfeitures, value   $ 1   2,132       2,133
Repurchase of restricted common stock, shares   (59,800)            
Repurchase of restricted common stock, value       (229)       (229)
Repurchase of common stock, shares   (1,190,420)            
Repurchase of common stock, value   $ (2) (4,632)         (4,634)
Net income (loss) attributable to noncontrolling interests in subsidiaries             181 181
Unrealized loss on foreign currency translation         88     88
Ending balance, shares at Dec. 31, 2018 0 49,639,319            
Ending balance, value at Dec. 31, 2018 $ 0 $ 50 (39,272) 651,156 0 (422,541) 1,847 191,240
Net loss attributable to Acacia Research Corporation           (17,115)   (17,115)
Issuance of shares of Series A redeemable convertible preferred stock, net of embedded derivative, Series A warrants, and issuance costs, shares 350,000              
Issuance of shares of Series A redeemable convertible preferred stock, net of embedded derivative, Series A warrants, and issuance costs, value $ 7,782              
Accretion of Series A redeemable convertible preferred stock to redemption value $ 307     (307)       (307)
Stock options exercised, shares   25,136            
Stock options exercised, value       79       79
Compensation expense for share-based awards, net of forfeitures, shares   706,532            
Compensation expense for share-based awards, net of forfeitures, value       1,075       1,075
Net income (loss) attributable to noncontrolling interests in subsidiaries             (14) (14)
Ending balance, shares at Dec. 31, 2019 350,000 50,370,987            
Ending balance, value at Dec. 31, 2019 $ 8,089 $ 50 $ (39,272) $ 652,003 $ 0 $ (439,656) $ 1,833 $ 174,958